5 employees
Capio Biosciences focuses on delivering high-value oncology diagnostics that can help inform patient care decisions and improve outcomes.
2015
$2.9M
from 1 investors over 1 rounds
Capio Biosciences raised $2.9M on January 5, 2017
Investors: Betta Pharmaceuticals Co., Ltd.